Last reviewed · How we verify

NCT03463356

Brief Shame Intervention Study

Completed NA Last updated 7 February 2019
What this trial tests

NA trial testing Shame Intervention in Shame in 14 participants. Completed in 30 June 2018.

Timeline
15 February 2018
Primary endpoint
30 June 2018
30 June 2018

Quick facts

Lead sponsorMiami University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment14
Start date15 February 2018
Primary completion30 June 2018
Estimated completion30 June 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Miami University

Who can join

Adults 18 to 100, any sex, with Shame or Social Anxiety Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current project will develop and test a brief 2-session shame intervention in individuals diagnosed with social anxiety disorder (SAD). Using a non-concurrent multiple baseline design, the investigators will determine whether the brief shame intervention leads to reductions in trait self-reported shame and state shame in response to an in vivo stressor task. The investigators will also evaluate the effect of changes in shame on trait SAD symptoms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Shame

Currently open trials in the same condition.

Other Miami University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03463356.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing